Skip to main navigation Skip to search Skip to main content

gyrA mutations in ciprofloxacin-resistant Bartonella bacilliformis strains obtained in vitro

Research output: Contribution to journalArticlepeer-review

32 Scopus citations

Abstract

We isolated and characterized mutants of Bartonella bacilliformis that are resistant to the fluoroquinolone antibiotic ciprofloxacin, which targets the A subunit of DNA gyrase. Mutants had single point mutations in the gyrA gene that changed either Asp-90 to Gly or Asp-95 to Asn and had 3- or 16-fold higher resistance, respectively, to ciprofloxacin than did wild-type B. bacilliformis. Asp-95 is homologous to Asp-87 of Escherichia coli GyrA and is a common residue mutated in fluoroquinolone-resistant strains of other bacteria. This is the first report of a mutation at an Asp-90 homologue, which corresponds to Asp-82 in E. coli GyrA.

Original languageEnglish
Pages (from-to)383-386
Number of pages4
JournalAntimicrobial Agents and Chemotherapy
Volume47
Issue number1
DOIs
StatePublished - Jan 1 2003

Funding

Funder number
R15AI045534

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Fingerprint

    Dive into the research topics of 'gyrA mutations in ciprofloxacin-resistant Bartonella bacilliformis strains obtained in vitro'. Together they form a unique fingerprint.

    Cite this